01 AI-Assisted Treatment Planning Improves Radiosurgery PrecisionThe radiosurgery market analysis shows that the need for accurate target identification and individualized treatment is encouraging the integration of AI into radiosurgery planning and outcome prediction. This transition supports more precise treatment planning, improves patient risk assessment, and helps clinicians identify individuals who may require closer post-treatment monitoring.
02 MRI-Guided Radiosurgery Enables Real-Time Treatment AdaptationThe need to account for anatomical changes during multi-session treatment is encouraging the adoption of MRI-guided radiosurgery and online adaptive workflows. This shift supports improved target coverage and normal-brain protection by allowing clinicians to adjust treatment plans according to anatomical changes during therapy.
01 Cancer Disease Burden Drive MarketThe rising incidence of cancer across different organ systems is increasing the need for effective and targeted treatment options, including radiosurgery. Healthcare providers use radiosurgery to treat selected tumors in the brain, lungs, liver, spine, and other anatomical sites by delivering concentrated radiation to abnormal tissues while limiting exposure to surrounding healthy structures. The clinical application of radiosurgery across multiple tumor types supports its adoption in specialized oncology centers and hospitals.
02 Preference for Minimally Invasive Cancer Treatments Increase Market DemandThe preference for treatment approaches that avoid conventional surgery is supporting the adoption of radiosurgery among eligible cancer patients. Radiosurgery delivers focused radiation without surgical incisions, helping reduce procedure-related complications and the need for extended hospitalization in appropriate cases. Its ability to provide targeted treatment with shorter recovery requirements encourages healthcare providers to include radiosurgery in treatment plans for selected tumors and neurological conditions.
03 Impact Analysis of Key Drivers in Radiosurgery MarketDriversMarket ImpactIncreasing Cancer Disease BurdenThe need for effective treatment options for brain, lung, liver, and other tumors increases the use of radiosurgery as a non-invasive treatment approach.Preference for Minimally Invasive Cancer TreatmentsPatients and healthcare providers favor non-invasive treatment options that reduce surgical complications, hospital stays, and recovery time, supporting radiosurgery adoption.Expansion of Specialized Cancer Treatment CentersThe establishment of dedicated oncology hospitals and radiation therapy centers increases access to radiosurgery equipment and specialized treatment services.Demand for Outpatient Cancer TreatmentRadiosurgery enables selected patients to receive precise radiation treatment without conventional surgical procedures or extended hospitalization, supporting its use in outpatient care settings.Improved Access to Oncology CareInvestments in cancer care infrastructure, radiation therapy facilities, and specialized medical services improve access to radiosurgery across established and emerging healthcare systems.
01 High Equipment Installation and Maintenance Costs Limit Healthcare Facility AdoptionRadiosurgery systems require substantial investments in advanced imaging technologies, precision treatment equipment, specialized facilities, and supporting infrastructure. Regular maintenance, software upgrades, and equipment calibration further increase the financial burden on healthcare providers. These high costs can discourage smaller hospitals and treatment centers from installing radiosurgery systems, limiting treatment availability and wider adoption.
02 Shortage of Skilled Medical Professionals Restricts Treatment AvailabilityRadiosurgery procedures require specialized expertise from neurosurgeons, radiation oncologists, medical physicists, and trained technical personnel to ensure accurate treatment planning and delivery. The limited availability of these professionals, particularly in developing and underserved regions, can restrict the number of facilities capable of providing radiosurgery services. This workforce shortage can delay treatment access and slow the expansion of radiosurgery services.
03 Impact Analysis of Key Restraints in Radiosurgery MarketRestraintsMarket ImpactHigh Equipment Installation and Maintenance CostsAdvanced radiosurgery systems require substantial capital investment, specialized facilities, and regular maintenance, limiting adoption among smaller hospitals and healthcare centers.Shortage of Skilled Medical ProfessionalsRadiosurgery requires trained neurosurgeons, radiation oncologists, medical physicists, and technical specialists, restricting treatment availability in regions with limited expertise.Risk of Radiation Exposure and Treatment-Related ComplicationsConcerns about radiation damage to surrounding healthy tissues and potential treatment complications can affect patient acceptance and clinical suitability.Limited Accessibility in Developing and Remote RegionsInadequate healthcare infrastructure, limited specialized treatment centers, and high treatment expenses restrict access to radiosurgery services.Stringent Regulatory and Clinical Safety RequirementsStrict equipment approval, radiation safety, and clinical validation requirements increase compliance expenses and can delay the adoption of advanced radiosurgery technologies.
01 Radiosurgery-Immunotherapy IntegrationOncology hospitals, cancer centers, radiation specialists, and pharmaceutical companies can combine radiosurgery with immunotherapy for selected cancer treatment pathways. Combination protocols create revenue opportunities through treatment packages, clinical collaborations, and demand for advanced radiation systems. Companies such as Varian and Elekta operate in advanced radiation oncology technologies.
02 Expansion of Outpatient ServicesHospitals, ambulatory treatment centers, and radiation oncology providers can deliver selected radiosurgery procedures without prolonged inpatient stays. Outpatient models create revenue through higher treatment throughput, facility utilization, procedure-based payments, and related patient services.
May 2026 Accuray Incorporated and the University of Wisconsin School of Medicine and Public Health announced a 10-year strategic research collaboration to advance personalized cancer treatment using Accuray’s adaptive radiation therapy technologies. The collaboration focuses on clinical research, education, training, and development of adaptive treatment approaches that support precision radiation therapy applications.
January 2026 Elekta received U.S. FDA 510(k) clearance for its Elekta Gamma Knife radiosurgery system to treat patients with refractory, drug-resistant mesial temporal lobe epilepsy. The regulatory approval expanded the clinical applications of Elekta’s stereotactic radiosurgery platform beyond traditional intracranial tumor treatments.
September 2025 Accuray launched the Accuray Stellar™ Solution, an advanced radiotherapy solution based on the Radixact® Treatment Delivery System. The platform introduced adaptive radiotherapy capabilities designed to provide clinicians with enhanced treatment flexibility and precision for individualized cancer care.
September 2025 Elekta announced that its Leksell Gamma Knife radiosurgery platform reached the milestone of treating more than two million patients globally. The milestone highlighted the continued clinical adoption of Gamma Knife technology in stereotactic radiosurgery applications.